Arthur Taveras - Nov 7, 2022 Form 4 Insider Report for X4 Pharmaceuticals, Inc (XFOR)

Role
Chief Scientific Officer
Signature
/s/ Adam S. Mostafa, attorney-in-fact
Stock symbol
XFOR
Transactions as of
Nov 7, 2022
Transactions value $
$0
Form type
4
Date filed
11/9/2022, 03:22 PM
Previous filing
Mar 1, 2022
Next filing
Feb 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XFOR Stock Appreciation Right Award $0 +1M $0.00 1M Nov 7, 2022 Common Stock 1M $1.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Appreciation Right will vest and become exercisable in equal annual installments (rounding down to the nearest whole share, except for the last installment) on the first, second, and third anniversaries of November 7, 2022, subject to the Reporting Person remaining an employee of the Issuer through and including each applicable vesting date.